• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增生异常综合征中的移植

Transplants in myelodysplastic syndromes.

作者信息

Wetzko Katrin, Platzbecker Uwe

机构信息

Medical Clinic 1, University Hospital "Carl-Gustav-Carus" at TUD, Fetscherstraße 74, 01307 Dresden, Germany.

Medical Clinic 1, University Hospital "Carl-Gustav-Carus" at TUD, Fetscherstraße 74, 01307 Dresden, Germany.

出版信息

Hematol Oncol Clin North Am. 2014 Dec;28(6):1011-22. doi: 10.1016/j.hoc.2014.08.012. Epub 2014 Sep 29.

DOI:10.1016/j.hoc.2014.08.012
PMID:25459176
Abstract

Myelodysplastic syndromes are one of the most common hematological disorders in the elderly. Therefore, an increase in the prevalence of de novo but also of secondary forms after prior chemotherapy or radiotherapy, respectively, is anticipated within the next years. Allogeneic stem cell transplantation is considered the only potentially curable therapy, but many patients are not eligible because of age or comorbidities. Reduced-intensity conditioning regimens have improved early tolerability of the procedure, although late effects remain a challenge in the care of these patients. However, hypomethylating agents have become available as alternative therapeutic approaches with a moderate toxicity profile.

摘要

骨髓增生异常综合征是老年人中最常见的血液系统疾病之一。因此,预计在未来几年,初发形式以及先前化疗或放疗后继发形式的发病率都会增加。异基因干细胞移植被认为是唯一可能治愈的疗法,但许多患者因年龄或合并症而不符合条件。降低强度的预处理方案改善了该程序的早期耐受性,尽管晚期效应在这些患者的护理中仍然是一个挑战。然而,低甲基化药物已成为具有中度毒性特征的替代治疗方法。

相似文献

1
Transplants in myelodysplastic syndromes.骨髓增生异常综合征中的移植
Hematol Oncol Clin North Am. 2014 Dec;28(6):1011-22. doi: 10.1016/j.hoc.2014.08.012. Epub 2014 Sep 29.
2
[Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review].[减低强度预处理异基因造血干细胞移植治疗骨髓增生异常综合征的研究进展 - 综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):969-74.
3
Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.异基因干细胞移植治疗成人骨髓增生异常综合征:移植前疾病负担的重要性。
Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.
4
Pretransplantation therapy with hypomethylating agents in patients with myelodysplastic syndromes receiving reduced-intensity conditioning regimens.接受减低强度预处理方案的骨髓增生异常综合征患者的移植前低甲基化药物治疗
Biol Blood Marrow Transplant. 2014 Sep;20(9):1260-1. doi: 10.1016/j.bbmt.2014.07.006. Epub 2014 Jul 11.
5
Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire.低强度/非清髓性预处理后 upfront 异基因干细胞移植治疗骨髓增生异常综合征患者:法国骨髓移植和细胞治疗协会的一项研究
Biol Blood Marrow Transplant. 2014 Sep;20(9):1349-55. doi: 10.1016/j.bbmt.2014.05.010. Epub 2014 May 14.
6
Which Patients Should Undergo Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes, and When Should We Do It?哪些骨髓增生异常综合征患者应接受异基因干细胞移植,以及我们应该何时进行移植?
Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S43-9. doi: 10.1016/j.clml.2015.04.002.
7
Pretransplantation 5-azacitidine in high-risk myelodysplastic syndrome.高危骨髓增生异常综合征的移植前5-氮杂胞苷治疗
Biol Blood Marrow Transplant. 2014 Jun;20(6):776-80. doi: 10.1016/j.bbmt.2014.02.008. Epub 2014 Feb 15.
8
Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of Relapse.异基因造血干细胞移植治疗骨髓增生异常综合征及预防复发。
Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):1-7. doi: 10.1016/j.clml.2020.10.008. Epub 2020 Oct 16.
9
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.低强度预处理用于骨髓增生异常综合征和急性髓系白血病的异基因造血干细胞移植
Curr Opin Oncol. 2007 Nov;19(6):660-6. doi: 10.1097/CCO.0b013e3282f0e188.
10
Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndrome.既往使用阿扎胞苷对骨髓增生异常综合征异基因造血移植结局的影响。
Pathol Oncol Res. 2015 Sep;21(4):1037-43. doi: 10.1007/s12253-015-9933-8. Epub 2015 Apr 3.